Table 2. English literature review of simultaneous and sequential liver kidney donation.
| Year | Number of cases | Liver Graft | Kidney Graft | Sim/Seq-(m,y) | Donor Death | Recipient Relation | Recipient Age |
Recipient Prim. Disease Liver/Kidney |
|
| Haberal M et al. (18) | 1992 | 1 (Turkey) | LLS | R-Op | Sim. | None | Mother | 23 y | Crn. HBV/NS |
| Kitajima et al. (20) Sato S et al. (29) Nakamura M et al. (26) Motoyoshil et al. (27) |
1996 2014 |
13 (Japan) | LLS (8)- Left (5) |
L (5) NA (8) |
Seq- 1.5 month to 4 year |
None | Mother (7) Father (5) Sibling (1) |
Ped (11) Adult (2) |
PHO Type 1 (7) Caroli/ARPKD (2) Cong. L fibr/ARPKD (1) Cong. Cholestas/NA (1) Biliary Atresia/Jeune Synd (1) Alagille SyndiAplastic KD (1) |
| Marujo WC et al. (19) | 1999 | 1 (Brazil) | Right | NA | Sim. | None | Child | 53 y | Cirrhosis/CKD |
| Unek T et al. (2) Astarcioglu L et al. (25) | 2001 2009 |
6 (Turkey) | LLS(4) -Op Left(1)-Op Right(1) Op |
R | Sim. (5) Seq .(1) – 11 d |
None | Mother 2 Sibling 2 Child 1 Spouse 1 | 9 y | PHO Type 1 (5) Crn. HBV/CKD (1) |
| Pacheco-Moreira et al. (32) | 2005 | 1 (Brazil) | Right | NA | Seq- 20 y | None | Sibling | Adult | Crn. HCV/NS |
| Rosenblatt GS et al. (30) | 2006 | 1 (USA) | LLS-Op | L | Seq | None | Mother | 1.5 y | PHO Type 1 |
| Moray G, Haberal M et al. (22) |
2002-2013 | 1 (Turkey) | NA | NA | Seq.-4 m | None | Relative | 10 y | PHO Type 1 |
| Mor E et al. (24) | 2013 | 2 (Israel) | Right Right |
L L |
Seq-4.5m Seq-20 d |
None | Father (2) | 17 y 17 y |
PHO Type 1 (2) |
| Kotb et al. (21) | 2010 2014 |
4 (Egypt) | LLS 4 -Op | NA | Sim. | None | Mother (1) Siblings (1) NA (2) |
Ped (4) | PHO Type 1 (4) |
| Khorsandi et al. (31) | 2016 | 2 (UK) | LLS- Op | NA | Seq-6 m | None | NA | 1 y/2 y | PHO Type 1 (2) |
| Henderson et al. (1) (US SRTR data) | 1994-2017 | 36 (US) | NA | NA | Seq- NA | None | NA (All type)* |
NA | NA |
| Angelico R et al. (28) | 2008-2018 | 5 (Italy) | LLS (Lap) LLS (Lap) LLS 3 -Op |
L (Lap) R(Lap) NA -3 |
Seq. 8 m Seq. 4 m Seq- NA |
None | Mother 1 Father 1 NA-3 |
1.5 y 3 y Ped (3) |
PHO Type 1 (5) |
| Ozer A et al. (23) | 2017-2018 | 4 (Turkey) | LLS(3 Right(1)- |
NA- Lap(3) | Sim. (1) Seq. (3)-4m |
None | Mother (2) Father (2) |
Ped (3) Adult (1) |
PHO Type 1 (4) |
| Gautier et al. (4) | 2019 | 1 (Russia) | LLS (Lap) | L (Lap) | Sim. | None | Mother | 2 y | Cong. L fibrosis/ARPKD |
| Nair A et al. (3) | 2020 | 5 (US) | Left 3 LLS 2 |
L 4 R 1 | Seq- 11 month to 9 year |
None | NA | NA | NA |
| LLS: Living liver left lateral sector donation, Left: Living liver left lobe donation, Right: Living liver right lobe donation, Sim.: Simultaneous living liver and kidney donation, Seq.: Sequential living liver kidney donation, R: Living right kidney donation, L: Living left kidney donation, KD: Kidney disease, Op: Open surgery, Chr: Chronic, L: Liver, ARPKD: Autosomal recessive polycystic kidney disease, PHO: Primary hyperoxaluria, d: Day, m: Month, Lap: Laparoscopic surgery, UK: United Kingdom, US: United States, Ped.: Pediatric. | |||||||||